首页 > 最新文献

Exploratory research in clinical and social pharmacy最新文献

英文 中文
Psychological safety perception in community pharmacies: A randomized controlled trial of agile interventions 社区药房的心理安全感:敏捷干预的随机对照试验
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-05-17 DOI: 10.1016/j.rcsop.2024.100452
Dragana Jocic

Background

Agile coaching, recognized as a more advanced methodology compared to education, is hypothesized to yield superior outcomes in enhancing psychological safety perception.

Objective

Investigating the effectiveness of agile interventions versus no intervention on psychological safety perception, this randomized controlled trial aimed to clarify outcomes.

Methods

The survey sample consisted of 54 licensed pharmacists, with each group comprising 18 participants: E1 underwent Agile Coaching, E2 underwent Agile Education, and C served as the control. After six weeks, psychological safety perception was measured using a validated scale, and statistical analyses, including the Kruskal-Wallis test and Mann-Whitney U test, were conducted.

Results

The group undergoing agile coaching showed the most substantial enhancements in psychological safety perception compared to others. Mann-Whitney U test revealed no significant difference in psychological safety perception between E1 and E2 groups before (Z = −0.938, p = 0.348) and after intervention (Z = −1.269, p = 0.204). Significant differences were observed between E1 and C both before (Z = −2.693, p = 0.007) and after intervention (Z = −1.414, p = 0.157). Significant differences were found between E2 and C before (p = 0.038) but not after intervention (p = 0.962).

Conclusions

The findings suggest that agile coaching could be an effective intervention for enhancing psychological safety in organizational settings, particularly in community pharmacies. Further research is warranted to explore long-term effects and generalize findings to broader contexts.

背景与教育相比,敏捷辅导被认为是一种更先进的方法,据推测,它在增强心理安全感方面能产生更好的效果。方法调查样本包括 54 名执业药师,每组 18 人:E1 组接受敏捷辅导,E2 组接受敏捷教育,C 组为对照组。六周后,使用经过验证的量表测量了心理安全感,并进行了统计分析,包括 Kruskal-Wallis 检验和 Mann-Whitney U 检验。Mann-Whitney U 检验显示,干预前(Z = -0.938,p = 0.348)和干预后(Z = -1.269,p = 0.204),E1 组和 E2 组在心理安全感方面没有显著差异。干预前(Z = -2.693,p = 0.007)和干预后(Z = -1.414,p = 0.157),E1 组和 C 组之间均存在显著差异。结论研究结果表明,敏捷教练可以有效地干预组织环境中的心理安全,尤其是在社区药房。有必要开展进一步研究,以探讨长期效果,并将研究结果推广到更广泛的环境中。
{"title":"Psychological safety perception in community pharmacies: A randomized controlled trial of agile interventions","authors":"Dragana Jocic","doi":"10.1016/j.rcsop.2024.100452","DOIUrl":"10.1016/j.rcsop.2024.100452","url":null,"abstract":"<div><h3>Background</h3><p>Agile coaching, recognized as a more advanced methodology compared to education, is hypothesized to yield superior outcomes in enhancing psychological safety perception.</p></div><div><h3>Objective</h3><p>Investigating the effectiveness of agile interventions versus no intervention on psychological safety perception, this randomized controlled trial aimed to clarify outcomes.</p></div><div><h3>Methods</h3><p>The survey sample consisted of 54 licensed pharmacists, with each group comprising 18 participants: E1 underwent Agile Coaching, E2 underwent Agile Education, and C served as the control. After six weeks, psychological safety perception was measured using a validated scale, and statistical analyses, including the Kruskal-Wallis test and Mann-Whitney <em>U</em> test, were conducted.</p></div><div><h3>Results</h3><p>The group undergoing agile coaching showed the most substantial enhancements in psychological safety perception compared to others. Mann-Whitney <em>U</em> test revealed no significant difference in psychological safety perception between E1 and E2 groups before (Z = −0.938, <em>p</em> = 0.348) and after intervention (Z = −1.269, <em>p</em> = 0.204). Significant differences were observed between E1 and C both before (Z = −2.693, <em>p</em> = 0.007) and after intervention (Z = −1.414, <em>p</em> = 0.157). Significant differences were found between E2 and C before (<em>p</em> = 0.038) but not after intervention (<em>p</em> = 0.962).</p></div><div><h3>Conclusions</h3><p>The findings suggest that agile coaching could be an effective intervention for enhancing psychological safety in organizational settings, particularly in community pharmacies. Further research is warranted to explore long-term effects and generalize findings to broader contexts.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100452"},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000490/pdfft?md5=0587fb500cb8153af3de5d95f5f4f3cd&pid=1-s2.0-S2667276624000490-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141036586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated dispensing cabinets and their impact on the rate of omitted and delayed doses: A systematic review 自动配药柜及其对漏服和延迟服药率的影响:系统回顾
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-05-08 DOI: 10.1016/j.rcsop.2024.100451
Emma Jeffrey, Melanie Dalby, Áine Walsh, Kit Lai

Use of automated dispensing cabinets (ADCs) is increasing in hospital settings. ADCs bring various potential benefits, among which are improvements to patient safety and reduction of medication errors. A core function of ADCs is to prevent medication stock outs by triggering an order when stock is reaching low levels. A quantifiable patient safety measure is the occurrence of omitted or delayed doses, which can range in severity from being negligible, to potentially fatal. The purpose of this review is to identify and synthesise the existing evidence regarding the impact of ADCs situated in secondary and tertiary care inpatient settings, on the rate of omitted and delayed doses as a specific subsection of medication errors. In April 2024 searches were conducted in Embase, PubMed and CINAHL, with additional articles discovered through citation searching and from colleagues. A total of 375 articles were returned from the search. Nine articles met the inclusion criteria. The most common reason for exclusion was due to lack of relevance. The included papers were focused on centres which had implemented six or fewer ADCs. The studies mostly presented findings which suggest ADCs have a positive impact on the rate of omitted or delayed doses, although crucially only two papers correlated missed doses due to unavailability of medications The studies highlighted other factors which should be considered prior to the implementation of ADCs. Factors included staffing requirement, type of stock held in the cabinets, and interoperability with other systems. Studies only reported omitted or missed doses, none reported results on delayed doses. It is widely accepted that ADCs can prevent medication unavailability but there is a paucity of evidence linking the improved availability of medications through the utilisation of ADCs with the perceived impact on missed or delayed doses. Further multi-centre studies are needed to determine this causality.

自动配药柜(ADC)在医院环境中的使用越来越多。自动配药柜可带来各种潜在的好处,其中包括改善患者安全和减少用药错误。自动配药柜的一个核心功能是通过在库存达到低水平时触发订单来防止药品缺货。漏服或延迟服药是一项可量化的患者安全措施,其严重程度从可忽略不计到可能致命。本综述旨在确定并综合现有证据,说明在二级和三级护理住院环境中使用 ADC 对漏服和延迟服药率(作为用药错误的一个具体分项)的影响。2024 年 4 月,我们在 Embase、PubMed 和 CINAHL 中进行了检索,并通过引文检索和同事提供的信息发现了其他文章。共检索到 375 篇文章。有 9 篇文章符合纳入标准。最常见的排除原因是缺乏相关性。纳入的论文主要集中在实施了六项或六项以下 ADC 的中心。大部分研究结果表明,ADC 对漏服或延迟服药率有积极影响,但重要的是,只有两篇论文与药物供应不足导致的漏服相关。这些因素包括人员配备要求、药柜库存类型以及与其他系统的互操作性。研究只报告了漏服或漏服的情况,没有报告延迟服药的结果。人们普遍认为 ADC 可以防止药物供应不足,但将使用 ADC 改善药物供应与漏服或延迟服药的预期影响联系起来的证据却很少。要确定这种因果关系,还需要进一步开展多中心研究。
{"title":"Automated dispensing cabinets and their impact on the rate of omitted and delayed doses: A systematic review","authors":"Emma Jeffrey,&nbsp;Melanie Dalby,&nbsp;Áine Walsh,&nbsp;Kit Lai","doi":"10.1016/j.rcsop.2024.100451","DOIUrl":"https://doi.org/10.1016/j.rcsop.2024.100451","url":null,"abstract":"<div><p>Use of automated dispensing cabinets (ADCs) is increasing in hospital settings. ADCs bring various potential benefits, among which are improvements to patient safety and reduction of medication errors. A core function of ADCs is to prevent medication stock outs by triggering an order when stock is reaching low levels. A quantifiable patient safety measure is the occurrence of omitted or delayed doses, which can range in severity from being negligible, to potentially fatal. The purpose of this review is to identify and synthesise the existing evidence regarding the impact of ADCs situated in secondary and tertiary care inpatient settings, on the rate of omitted and delayed doses as a specific subsection of medication errors. In April 2024 searches were conducted in Embase, PubMed and CINAHL, with additional articles discovered through citation searching and from colleagues. A total of 375 articles were returned from the search. Nine articles met the inclusion criteria. The most common reason for exclusion was due to lack of relevance. The included papers were focused on centres which had implemented six or fewer ADCs. The studies mostly presented findings which suggest ADCs have a positive impact on the rate of omitted or delayed doses, although crucially only two papers correlated missed doses due to unavailability of medications The studies highlighted other factors which should be considered prior to the implementation of ADCs. Factors included staffing requirement, type of stock held in the cabinets, and interoperability with other systems. Studies only reported omitted or missed doses, none reported results on delayed doses. It is widely accepted that ADCs can prevent medication unavailability but there is a paucity of evidence linking the improved availability of medications through the utilisation of ADCs with the perceived impact on missed or delayed doses. Further multi-centre studies are needed to determine this causality.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100451"},"PeriodicalIF":0.0,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000489/pdfft?md5=eedc2895f9626c31e74a1774533fbaaf&pid=1-s2.0-S2667276624000489-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140910388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to Parkinson's disease medication: A case study to illustrate reasons for non-adherence, implications for practice and engaging under-represented participants in research 帕金森病药物治疗的依从性:通过案例研究说明不坚持服药的原因、对实践的影响以及让代表性不足的参与者参与研究的意义
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-05-07 DOI: 10.1016/j.rcsop.2024.100450
Delyth James , Joshua Smith , Emma Lane , Rhian Thomas , Sarah Brown , Heidi Seage

Parkinson's disease (PD) is a progressive neurodegenerative disease which primarily presents with the core symptoms of rigidity, postural instability, tremor, and bradykinesia. Non-adherence to prescribed PD treatments can have significant ramifications, such as poor symptom control and greater disease burden. Reasons for poor adherence are multifaceted, particularly when medication regimens are complex and often based on perceptual and practical barriers. Additionally, engaging fully non-adherent patients in research is challenging since they may have dropped out of service provision, yet their contribution is vital to fully understand the rationale for non-adherence.

This paper aims to present a case study on the perspectives of one person with PD, a participant in a previously published qualitative study investigating the barriers and facilitators to medication adherence in PD. In this paper, the participant's diagnostic journey is described, and experiences of medical consultations are summarised to explain their reasons for not adhering to any of the standard UK PD treatments prescribed. The participant's preferences for using Vitamin B1 (thiamine) injections to manage the symptoms are reported and the rationale for doing so is discussed. We consider the case through the lens of a behavioural science approach, drawing on health psychology theory, the Theoretical Domains Framework (TDF), to inform the review and the practical challenges faced when analysing the data for this participant. Implications for pharmacy practice, in particular, are also put forward with view to ensuring that patients such as Mr. Wilkinson are provided with the opportunity to discuss treatment choices and self-management of long-term conditions such as PD. We also discuss the importance of reaching under-represented members of the population in medication adherence research, which embraces the principles of equality, diversity, and inclusion in research.

帕金森病(PD)是一种进行性神经退行性疾病,主要表现为僵直、姿势不稳、震颤和运动迟缓等核心症状。不遵从帕金森病处方治疗会造成严重后果,如症状控制不佳和疾病负担加重。治疗依从性差的原因是多方面的,尤其是当药物治疗方案复杂且往往存在感知和实际障碍时。此外,让完全不坚持服药的患者参与研究具有挑战性,因为他们可能已经放弃了服务,但他们的贡献对于充分了解不坚持服药的原因至关重要。本文旨在介绍一个病例研究,从一名帕金森病患者的角度出发,该患者曾参与过一项先前发表的定性研究,调查帕金森病患者坚持服药的障碍和促进因素。本文描述了该参与者的诊断过程,并总结了其就医经历,以解释其不坚持任何英国标准帕金森病处方治疗的原因。我们报告了该患者使用维生素 B1(硫胺素)注射来控制症状的偏好,并讨论了这样做的理由。我们从行为科学的角度来考虑该病例,借鉴健康心理学理论、理论领域框架(TDF),为回顾和分析该参与者的数据时所面临的实际挑战提供信息。我们还特别提出了对药学实践的启示,以确保像威尔金森先生这样的患者有机会讨论治疗选择和对帕金森病等长期疾病的自我管理。我们还讨论了在用药依从性研究中接触代表性不足的人群的重要性,这体现了研究中的平等、多样性和包容性原则。
{"title":"Adherence to Parkinson's disease medication: A case study to illustrate reasons for non-adherence, implications for practice and engaging under-represented participants in research","authors":"Delyth James ,&nbsp;Joshua Smith ,&nbsp;Emma Lane ,&nbsp;Rhian Thomas ,&nbsp;Sarah Brown ,&nbsp;Heidi Seage","doi":"10.1016/j.rcsop.2024.100450","DOIUrl":"https://doi.org/10.1016/j.rcsop.2024.100450","url":null,"abstract":"<div><p>Parkinson's disease (PD) is a progressive neurodegenerative disease which primarily presents with the core symptoms of rigidity, postural instability, tremor, and bradykinesia. Non-adherence to prescribed PD treatments can have significant ramifications, such as poor symptom control and greater disease burden. Reasons for poor adherence are multifaceted, particularly when medication regimens are complex and often based on perceptual and practical barriers. Additionally, engaging fully non-adherent patients in research is challenging since they may have dropped out of service provision, yet their contribution is vital to fully understand the rationale for non-adherence.</p><p>This paper aims to present a case study on the perspectives of one person with PD, a participant in a previously published qualitative study investigating the barriers and facilitators to medication adherence in PD. In this paper, the participant's diagnostic journey is described, and experiences of medical consultations are summarised to explain their reasons for not adhering to any of the standard UK PD treatments prescribed. The participant's preferences for using Vitamin B1 (thiamine) injections to manage the symptoms are reported and the rationale for doing so is discussed. We consider the case through the lens of a behavioural science approach, drawing on health psychology theory, the Theoretical Domains Framework (TDF), to inform the review and the practical challenges faced when analysing the data for this participant. Implications for pharmacy practice, in particular, are also put forward with view to ensuring that patients such as Mr. Wilkinson are provided with the opportunity to discuss treatment choices and self-management of long-term conditions such as PD. We also discuss the importance of reaching under-represented members of the population in medication adherence research, which embraces the principles of equality, diversity, and inclusion in research.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100450"},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000477/pdfft?md5=b6ee1a92767df365337243e676bac000&pid=1-s2.0-S2667276624000477-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140952398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Considerations for conducting a scoping review in pharmacy education 开展药学教育范围界定审查的注意事项
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-24 DOI: 10.1016/j.rcsop.2024.100448
Cherie Lucas , Shane P. Desselle

Interrogating the literature is among the first steps a researcher undertakes when actuating a research project or also when any scholar might seek to know what has been done in an area, best practices for conducting a certain activity, or simply to seek answers for a question ranging from one's own personal curiosity to those that might affect departmental or institutional guidance. Decisions on the type of review process to undertake is one that is not taken lightly. This methods commentary outlines the reasons for conducting a scoping review versus a systematic review for topics related to pharmacy education. Considerations for conducting the scoping review are outlined including considerations for writing a protocol prior to conducting a scoping review, to potential platforms to use for transparency of sharing data, processes related to guidelines for data extraction and types of search strategies utilized.

研究人员在开展研究项目时,或者任何学者在寻求了解某一领域的研究成果、开展某项活动的最佳实践时,或者仅仅是为了寻求从个人好奇心到可能影响部门或机构指导的问题的答案时,审阅文献是首先要做的工作之一。决定开展哪种类型的审查过程并非轻而易举。本方法评论概述了针对药学教育相关主题开展范围综述与系统综述的原因。本文概述了进行范围界定综述的注意事项,包括在进行范围界定综述之前编写规程的注意事项、为提高数据共享的透明度而可能使用的平台、与数据提取指南相关的流程以及所使用的检索策略类型。
{"title":"Considerations for conducting a scoping review in pharmacy education","authors":"Cherie Lucas ,&nbsp;Shane P. Desselle","doi":"10.1016/j.rcsop.2024.100448","DOIUrl":"10.1016/j.rcsop.2024.100448","url":null,"abstract":"<div><p>Interrogating the literature is among the first steps a researcher undertakes when actuating a research project or also when any scholar might seek to know what has been done in an area, best practices for conducting a certain activity, or simply to seek answers for a question ranging from one's own personal curiosity to those that might affect departmental or institutional guidance. Decisions on the type of review process to undertake is one that is not taken lightly. This methods commentary outlines the reasons for conducting a scoping review versus a systematic review for topics related to pharmacy education. Considerations for conducting the scoping review are outlined including considerations for writing a protocol prior to conducting a scoping review, to potential platforms to use for transparency of sharing data, processes related to guidelines for data extraction and types of search strategies utilized.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100448"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000441/pdfft?md5=56531665687fb77bf44e5df10f8aaef0&pid=1-s2.0-S2667276624000441-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140758413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical public health competencies for Thai pharmacists: A scoping review with expert consultation 泰国药剂师的医药公共卫生能力:专家咨询范围审查
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-22 DOI: 10.1016/j.rcsop.2024.100444
Thanayut Auimekhakul , Siritree Suttajit , Puckwipa Suwannaprom

Background

Thai pharmacists' roles have increasingly shifted to a system-focused role in providing public health services. A competency framework in this area is essential to workforce development.

Objective

This study aimed to summarize and synthesize the literature on pharmaceutical public health competencies of Thai pharmacists.

Methods

The Scopus, MEDLINE, and Web of Science (Clarivate) databases were searched. The search criteria included “public health”, “health promotion”, “primary care”, “community pharmacy”, “pharmacy” and “pharmacist”. Documents published in English and Thai between January 2011 and December 2020 were also examined. Unpublished documents were included. A 3-step inductive coding technique was used to develop the competency framework. To validate the findings, a 2-round, modified Delphi method was employed with 20 Thai pharmaceutical specialists between August 2022 and January 2023. The Scale-level Content Validity Index (S-CVI) was used to assess validity.

Results

The database search yielded 1429 articles. Fifty-seven articles were selected. The analysis identified 5 competency domains. The domains, along with their related competency elements and behavioral statements, were provided for expert assessment. The S-CVI scores in the first and second rounds were 0.78 and 0.93, respectively. The terminology and categories of competencies have been improved. This outcome resulted in a pharmaceutical public health competency framework for Thai pharmacists. The framework consists of 5 competency domains: 1) individual and family health promotion (3 competency elements with 10 behavioral statements), 2) community empowerment for well-being communities (6 competency elements with 23 behavioral statements), 3) information management and evidence-based practice (3 competency elements with 10 behavioral statements), 4) communication for health promotion (3 competency elements with 6 behavioral statements), and 5) pharmacoepidemiology and support for public health emergencies and epidemics (2 competency elements with 5 behavioral statements).

Conclusion

Pharmaceutical public health competencies for Thai pharmacists were developed through extensive literature review and expert consultation.

背景泰国药剂师的角色日益转变为以系统为重点提供公共卫生服务。本研究旨在总结和归纳有关泰国药剂师医药公共卫生能力的文献。研究方法检索了 Scopus、MEDLINE 和 Web of Science (Clarivate) 数据库。检索标准包括 "公共卫生"、"健康促进"、"初级保健"、"社区药房"、"药房 "和 "药剂师"。此外,还研究了 2011 年 1 月至 2020 年 12 月期间用英语和泰语发表的文献。未发表的文献也包括在内。采用三步归纳编码技术制定了能力框架。为了验证研究结果,2022 年 8 月至 2023 年 1 月期间,20 位泰国制药专家采用了两轮改良德尔菲法。采用量表级内容效度指数(S-CVI)评估有效性。结果分析确定了 5 个能力领域。这些领域及其相关的能力要素和行为陈述已提供给专家评估。第一轮和第二轮的 S-CVI 分数分别为 0.78 和 0.93。能力的术语和类别也得到了改进。这一成果产生了泰国药剂师医药公共卫生能力框架。该框架包括 5 个能力领域:1) 促进个人和家庭健康(3 个能力要素,10 个行为陈述);2) 增强社区能力,促进社区福祉(6 个能力要素,23 个行为陈述);3) 信息管理和循证实践(3 个能力要素,10 个行为陈述);4) 促进健康的沟通(3 个能力要素,6 个行为陈述);5) 药物流行病学和支持公共卫生突发事件和流行病(2 个能力要素,5 个行为陈述)。结论泰国药剂师的药品公共卫生能力是通过广泛的文献查阅和专家咨询制定的。
{"title":"Pharmaceutical public health competencies for Thai pharmacists: A scoping review with expert consultation","authors":"Thanayut Auimekhakul ,&nbsp;Siritree Suttajit ,&nbsp;Puckwipa Suwannaprom","doi":"10.1016/j.rcsop.2024.100444","DOIUrl":"10.1016/j.rcsop.2024.100444","url":null,"abstract":"<div><h3>Background</h3><p>Thai pharmacists' roles have increasingly shifted to a system-focused role in providing public health services. A competency framework in this area is essential to workforce development.</p></div><div><h3>Objective</h3><p>This study aimed to summarize and synthesize the literature on pharmaceutical public health competencies of Thai pharmacists.</p></div><div><h3>Methods</h3><p>The Scopus, MEDLINE, and Web of Science (Clarivate) databases were searched. The search criteria included “public health”, “health promotion”, “primary care”, “community pharmacy”, “pharmacy” and “pharmacist”. Documents published in English and Thai between January 2011 and December 2020 were also examined. Unpublished documents were included. A 3-step inductive coding technique was used to develop the competency framework. To validate the findings, a 2-round, modified Delphi method was employed with 20 Thai pharmaceutical specialists between August 2022 and January 2023. The Scale-level Content Validity Index (S-CVI) was used to assess validity.</p></div><div><h3>Results</h3><p>The database search yielded 1429 articles. Fifty-seven articles were selected. The analysis identified 5 competency domains. The domains, along with their related competency elements and behavioral statements, were provided for expert assessment. The S-CVI scores in the first and second rounds were 0.78 and 0.93, respectively. The terminology and categories of competencies have been improved. This outcome resulted in a pharmaceutical public health competency framework for Thai pharmacists. The framework consists of 5 competency domains: 1) individual and family health promotion (3 competency elements with 10 behavioral statements), 2) community empowerment for well-being communities (6 competency elements with 23 behavioral statements), 3) information management and evidence-based practice (3 competency elements with 10 behavioral statements), 4) communication for health promotion (3 competency elements with 6 behavioral statements), and 5) pharmacoepidemiology and support for public health emergencies and epidemics (2 competency elements with 5 behavioral statements).</p></div><div><h3>Conclusion</h3><p>Pharmaceutical public health competencies for Thai pharmacists were developed through extensive literature review and expert consultation.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100444"},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000404/pdfft?md5=3d869070a940db8a905287535c2379c8&pid=1-s2.0-S2667276624000404-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140762601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European community pharmacists practice in tackling influenza 欧洲社区药剂师应对流感的实践
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-22 DOI: 10.1016/j.rcsop.2024.100447
Marleen Haems , Mauro Lanzilotto , Andrea Mandelli , Hélder Mota-Filipe , Ema Paulino , Beata Plewka , Olivier Rozaire , Jens Zeiger

Background

In many European countries, flu vaccination coverage rates are below the 75% target. During the COVID-19 pandemic, many pharmacists around Europe were involved as vaccine administrators and demonstrated positive results in improving vaccine uptake. This paper explores the challenges, accomplishments, and best practices of various European pharmacists' associations in administering vaccines and positively contributing to public health.

Methods

Eight pharmacists representing various associations from different countries across Europe (Italy, Belgium, Poland, Portugal, France, and Germany) convened to discuss their role as vaccination providers, the advantages, and strategies for improvement, and to identify barriers and gaps in the vaccination administration process, especially focusing on the administration of seasonal flu vaccines.

Results

Currently, 15 European countries allow community pharmacists to dispense and administer flu vaccines. Among the ones that attended the meeting, Portugal initiated the flu immunization program at the pharmacy earliest, before the COVID era, but in other countries, the process started only in the last couple of years. Initial hesitancy and reluctance by other HCPs or institutions were overcome as the pilot projects showed positive and cost-effective public health results. Today, pharmacists are considered crucial professional figures to provide immunization services against COVID-19, the flu, and other vaccine-preventable diseases, and pursue important public health goals.

Key takeaways to enhance the pharmacist's role in providing immunization services against vaccine-preventable diseases include improving interaction with policymakers and the public, generating real-world evidence highlighting public health benefits, and ensuring ongoing professional education and training for pharmacists.

Conclusion

Vaccinating pharmacists are gaining recognition of their role and the benefits derived from their broader involvement in the healthcare system, including immunization programs. Further efforts are needed in each country for an adequate recognition of the profession and a broader utilization of pharmacy services to exploit the benefit of immunization, especially against the flu.

背景在许多欧洲国家,流感疫苗接种率低于 75% 的目标。在 COVID-19 大流行期间,欧洲的许多药剂师作为疫苗管理者参与其中,并在提高疫苗接种率方面取得了积极成果。方法来自欧洲不同国家(意大利、比利时、波兰、葡萄牙、法国和德国)的八位药剂师代表不同的协会召开会议,讨论他们作为疫苗接种提供者的角色、优势和改进策略,并找出疫苗接种管理过程中的障碍和差距,尤其关注季节性流感疫苗的接种。在参加会议的国家中,葡萄牙在 COVID 时代之前最早在药房启动了流感免疫计划,而其他国家则在最近几年才开始这一进程。随着试点项目显示出积极和具有成本效益的公共卫生成果,其他 HCP 或机构最初的犹豫和不情愿都被克服了。如今,药剂师被认为是提供针对 COVID-19、流感和其他疫苗可预防疾病的免疫服务的重要专业人士,并致力于实现重要的公共卫生目标。加强药剂师在提供针对疫苗可预防疾病的免疫接种服务中的作用的主要启示包括:改善与政策制定者和公众的互动,生成突出公共卫生益处的真实证据,以及确保对药剂师进行持续的专业教育和培训。每个国家都需要进一步努力,以充分认可药剂师这一职业,并更广泛地利用药剂服务来发挥免疫接种(尤其是预防流感)的益处。
{"title":"European community pharmacists practice in tackling influenza","authors":"Marleen Haems ,&nbsp;Mauro Lanzilotto ,&nbsp;Andrea Mandelli ,&nbsp;Hélder Mota-Filipe ,&nbsp;Ema Paulino ,&nbsp;Beata Plewka ,&nbsp;Olivier Rozaire ,&nbsp;Jens Zeiger","doi":"10.1016/j.rcsop.2024.100447","DOIUrl":"10.1016/j.rcsop.2024.100447","url":null,"abstract":"<div><h3>Background</h3><p>In many European countries, flu vaccination coverage rates are below the 75% target. During the COVID-19 pandemic, many pharmacists around Europe were involved as vaccine administrators and demonstrated positive results in improving vaccine uptake. This paper explores the challenges, accomplishments, and best practices of various European pharmacists' associations in administering vaccines and positively contributing to public health.</p></div><div><h3>Methods</h3><p>Eight pharmacists representing various associations from different countries across Europe (Italy, Belgium, Poland, Portugal, France, and Germany) convened to discuss their role as vaccination providers, the advantages, and strategies for improvement, and to identify barriers and gaps in the vaccination administration process, especially focusing on the administration of seasonal flu vaccines.</p></div><div><h3>Results</h3><p>Currently, 15 European countries allow community pharmacists to dispense and administer flu vaccines. Among the ones that attended the meeting, Portugal initiated the flu immunization program at the pharmacy earliest, before the COVID era, but in other countries, the process started only in the last couple of years. Initial hesitancy and reluctance by other HCPs or institutions were overcome as the pilot projects showed positive and cost-effective public health results. Today, pharmacists are considered crucial professional figures to provide immunization services against COVID-19, the flu, and other vaccine-preventable diseases, and pursue important public health goals.</p><p>Key takeaways to enhance the pharmacist's role in providing immunization services against vaccine-preventable diseases include improving interaction with policymakers and the public, generating real-world evidence highlighting public health benefits, and ensuring ongoing professional education and training for pharmacists.</p></div><div><h3>Conclusion</h3><p>Vaccinating pharmacists are gaining recognition of their role and the benefits derived from their broader involvement in the healthcare system, including immunization programs. Further efforts are needed in each country for an adequate recognition of the profession and a broader utilization of pharmacy services to exploit the benefit of immunization, especially against the flu.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100447"},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266727662400043X/pdfft?md5=64bd1572ab2acc2c60e42d64b65be56d&pid=1-s2.0-S266727662400043X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare professionals' experiences with the use of antipsychotics in dementia 医护人员在护理痴呆症患者和使用抗精神病药物方面的经验
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-21 DOI: 10.1016/j.rcsop.2024.100446
Sidsel Maria Jørgensen , Laura Victoria Jedig Lech , Charlotte Vermehren , Michaela L. Schiøtz , Jon Trærup Andersen , Kristian Karstoft , Tina Andersen , Stine Vest Hansen , Hanne Birke

Background

Antipsychotics are commonly administered to nursing home residents with dementia, despite the associated risk of severe adverse events.

Objective

This study aimed to explore healthcare professionals' experiences in caring for nursing home residents with dementia, with a focus on rationales behind the use of antipsychotics.

Method

Twelve semi-structured interviews with healthcare professionals' from Danish nursing homes were conducted and analyzed using the method Systematic Text Condensation.

Results

Nonpharmacological interventions were reported as the primary approach to care and the first-choice treatment for behavioral and psychological symptoms of dementia (BPSD). Use of antipsychotics was considered to serve as a last resort, reserved for residents with severe symptoms. However, most informants preferred a more limited use. The study identified four main barriers to reduce the use of antipsychotics: “Scarcity of resources”, “Perceiving antipsychotic use to provide relieve”, “Reluctance towards deprescribing” and “Limited access to medical counseling”, and three potential enablers: “Updating knowledge and nonpharmacological competencies”, “Management support and clear procedures” and “Regularity in interdisciplinary collaboration”.

Conclusion

The treatment and care were reported as primarily following guidelines in BPSD. Several barriers were perceived to challenge the healthcare professionals' preference of limited use of antipsychotics. To further reduce the use, this study highlights the importance of understanding the adverse effects caused by limited resources, enhancing employee knowledge and competencies and ensuring regular interprofessional collaboration for assessing and reassessing the need to use antipsychotics.

背景尽管抗精神病药物有导致严重不良事件的相关风险,但对患有痴呆症的疗养院住户使用这种药物的情况却很普遍。研究目的本研究旨在探讨医护人员在护理患有痴呆症的疗养院住户时的经验,重点关注使用抗精神病药物背后的理由。方法对丹麦养老院的医护人员进行了 12 次半结构式访谈,并采用系统文本浓缩法对访谈结果进行了分析。结果显示,非药物干预是护理的主要方法,也是痴呆症行为和心理症状 (BPSD) 的首选治疗方法。抗精神病药物的使用被认为是最后的手段,仅用于症状严重的患者。然而,大多数知情者倾向于更有限度地使用抗精神病药物。研究发现了减少使用抗精神病药物的四大障碍:"资源匮乏"、"认为使用抗精神病药物可以缓解病情"、"不愿意取消处方 "和 "获得医疗咨询的机会有限",以及三个潜在的促进因素:"结论 据报告,治疗和护理主要遵循 BPSD 指南。医护人员在有限使用抗精神病药物方面遇到了一些障碍。为进一步减少抗精神病药物的使用,本研究强调了了解有限资源造成的不良影响、增强员工的知识和能力以及确保定期开展跨专业合作以评估和重新评估使用抗精神病药物的必要性的重要性。
{"title":"Healthcare professionals' experiences with the use of antipsychotics in dementia","authors":"Sidsel Maria Jørgensen ,&nbsp;Laura Victoria Jedig Lech ,&nbsp;Charlotte Vermehren ,&nbsp;Michaela L. Schiøtz ,&nbsp;Jon Trærup Andersen ,&nbsp;Kristian Karstoft ,&nbsp;Tina Andersen ,&nbsp;Stine Vest Hansen ,&nbsp;Hanne Birke","doi":"10.1016/j.rcsop.2024.100446","DOIUrl":"10.1016/j.rcsop.2024.100446","url":null,"abstract":"<div><h3>Background</h3><p>Antipsychotics are commonly administered to nursing home residents with dementia, despite the associated risk of severe adverse events.</p></div><div><h3>Objective</h3><p>This study aimed to explore healthcare professionals' experiences in caring for nursing home residents with dementia, with a focus on rationales behind the use of antipsychotics.</p></div><div><h3>Method</h3><p>Twelve semi-structured interviews with healthcare professionals' from Danish nursing homes were conducted and analyzed using the method Systematic Text Condensation.</p></div><div><h3>Results</h3><p>Nonpharmacological interventions were reported as the primary approach to care and the first-choice treatment for behavioral and psychological symptoms of dementia (BPSD). Use of antipsychotics was considered to serve as a last resort, reserved for residents with severe symptoms. However, most informants preferred a more limited use. The study identified four main barriers to reduce the use of antipsychotics: <em>“Scarcity of resources”, “Perceiving antipsychotic use to provide relieve”, “Reluctance towards deprescribing”</em> and <em>“Limited access to medical counseling”,</em> and three potential enablers: “<em>Updating knowledge and nonpharmacological competencies</em>”, “<em>Management support and clear procedures</em>” and “<em>Regularity in interdisciplinary collaboration</em>”.</p></div><div><h3>Conclusion</h3><p>The treatment and care were reported as primarily following guidelines in BPSD. Several barriers were perceived to challenge the healthcare professionals' preference of limited use of antipsychotics. To further reduce the use, this study highlights the importance of understanding the adverse effects caused by limited resources, enhancing employee knowledge and competencies and ensuring regular interprofessional collaboration for assessing and reassessing the need to use antipsychotics.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100446"},"PeriodicalIF":0.0,"publicationDate":"2024-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000428/pdfft?md5=6930f3c4497fe03b980abfbd3c68ea35&pid=1-s2.0-S2667276624000428-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140766477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occupational burnout and job satisfaction among community pharmacists 社区药剂师的职业倦怠和工作满意度
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-17 DOI: 10.1016/j.rcsop.2024.100445
Ilias Katsogiannis , Eirini Manara , Aliki Peletidi , Angeliki Bistaraki , Theodoros Constantinides , Christos Kontogiorgis

Introduction

Community pharmacists (CPs) are the most accessible healthcare professionals in primary care due to pharmacies' open-door policy and convenience, resulting in high patient and prescription volumes, and numerous free-of-charge consultations. Therefore, they are at high risk for burnout.

Objectives

The primary objective of this study was to assess the levels of burnout among community pharmacists in Greece, marking the first investigation of its kind within the country. Additionally, this study aimed to explore potential correlations between demographic variables and other health-related factors with burnout scores.

Methods

This study used a quantitative cross-sectional design involving two validated questionnaires(the Greek version of Maslach (MBI) questionnaire and the SF-36 questionnaire). Prior to data collection, all the relevant documentation was approved by the Metropolitan College Research Ethics Committee and was adopted under the auspices of the Panhellenic Pharmaceutical Association. Random sampling was used. Data collection period was July to August 2022.

Results

A total of 368 responses were included in the analysis, with the majority being pharmacy-owners (n = 292, 79.3%). Notably, a significant proportion of respondents were female practitioners working within community pharmacy settings (n = 230, 62.5%). Analysis revealed that the sample exhibited low levels of personal achievement (M = 30.99, SD = 6.41), high levels of emotional exhaustion (M = 41.73, SD = 6.94), and moderate levels of depersonalization (M = 23.38, SD = 3.78), indicative of substantial occupational burnout. Furthermore, gender had a discernible impact on depersonalization, with women scoring higher than men (t = −3.29, p < 0.01). Pharmacists who identified medicine shortages as their primary challenge in daily practice reported lower emotional burnout and depersonalization, albeit with a diminished sense of accomplishment (t = −2.62, p < 0.01).

Conclusions

This study sheds light on burnout levels and health-related quality of life among community pharmacists in Greece.

导言社区药剂师(CP)是基层医疗机构中最容易接触到的医疗保健专业人员,因为药店的开放政策和便利性,导致了大量的患者和处方,以及大量的免费咨询。本研究的主要目的是评估希腊社区药剂师的职业倦怠程度,这在希腊尚属首次。此外,本研究还旨在探讨人口统计学变量和其他健康相关因素与职业倦怠评分之间的潜在相关性。方法本研究采用定量横断面设计,涉及两份经过验证的问卷(希腊版马斯拉奇(MBI)问卷和 SF-36 问卷)。在收集数据之前,所有相关文件均已获得大都会学院研究伦理委员会的批准,并在泛希腊医药协会的支持下通过。采用随机抽样。数据收集期为 2022 年 7 月至 8 月。结果共有 368 份回复被纳入分析,其中大多数为药店所有者(n = 292,79.3%)。值得注意的是,很大一部分受访者是在社区药房工作的女性从业者(n = 230,62.5%)。分析表明,样本表现出较低的个人成就感(M = 30.99,SD = 6.41)、较高的情感衰竭(M = 41.73,SD = 6.94)和中等程度的人格解体(M = 23.38,SD = 3.78),表明存在严重的职业倦怠。此外,性别对人格解体有明显影响,女性得分高于男性(t = -3.29,p <0.01)。这项研究揭示了希腊社区药剂师的职业倦怠水平和与健康相关的生活质量。
{"title":"Occupational burnout and job satisfaction among community pharmacists","authors":"Ilias Katsogiannis ,&nbsp;Eirini Manara ,&nbsp;Aliki Peletidi ,&nbsp;Angeliki Bistaraki ,&nbsp;Theodoros Constantinides ,&nbsp;Christos Kontogiorgis","doi":"10.1016/j.rcsop.2024.100445","DOIUrl":"https://doi.org/10.1016/j.rcsop.2024.100445","url":null,"abstract":"<div><h3>Introduction</h3><p>Community pharmacists (CPs) are the most accessible healthcare professionals in primary care due to pharmacies' open-door policy and convenience, resulting in high patient and prescription volumes, and numerous free-of-charge consultations. Therefore, they are at high risk for burnout.</p></div><div><h3>Objectives</h3><p>The primary objective of this study was to assess the levels of burnout among community pharmacists in Greece, marking the first investigation of its kind within the country. Additionally, this study aimed to explore potential correlations between demographic variables and other health-related factors with burnout scores<strong>.</strong></p></div><div><h3>Methods</h3><p>This study used a quantitative cross-sectional design involving two validated questionnaires(the Greek version of Maslach (MBI) questionnaire and the SF-36 questionnaire). Prior to data collection, all the relevant documentation was approved by the Metropolitan College Research Ethics Committee and was adopted under the auspices of the Panhellenic Pharmaceutical Association. Random sampling was used. Data collection period was July to August 2022.</p></div><div><h3>Results</h3><p>A total of 368 responses were included in the analysis, with the majority being pharmacy-owners (<em>n</em> = 292, 79.3%). Notably, a significant proportion of respondents were female practitioners working within community pharmacy settings (<em>n</em> = 230, 62.5%). Analysis revealed that the sample exhibited low levels of personal achievement (M = 30.99, SD = 6.41), high levels of emotional exhaustion (M = 41.73, SD = 6.94), and moderate levels of depersonalization (M = 23.38, SD = 3.78), indicative of substantial occupational burnout. Furthermore, gender had a discernible impact on depersonalization, with women scoring higher than men (<em>t</em> = −3.29, <em>p</em> &lt; 0.01). Pharmacists who identified medicine shortages as their primary challenge in daily practice reported lower emotional burnout and depersonalization, albeit with a diminished sense of accomplishment (<em>t</em> = −2.62, <em>p</em> &lt; 0.01<strong>)</strong>.</p></div><div><h3>Conclusions</h3><p>This study sheds light on burnout levels and health-related quality of life among community pharmacists in Greece.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100445"},"PeriodicalIF":0.0,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000416/pdfft?md5=5a8773da770a2d6b1ccdad87defb2b92&pid=1-s2.0-S2667276624000416-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140818436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender balance in Australian pharmacy organisations: Are we there yet? 澳大利亚药学机构中的性别平衡:我们到了吗?
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-12 DOI: 10.1016/j.rcsop.2024.100442
Thao Linh Pham , Gregory M. Peterson , Alicia Martin , Mark Naunton

Introduction

In the dynamic landscape of healthcare, pharmacists play a critical role in ensuring the well-being of communities, and having solid professional organisations to support pharmacists is essential in crucial activities, including continuing education, advocacy and establishing service standards. Eight pharmacy organisations play vital roles in representing pharmacists in various sectors and collectively contribute to developing, regulating, and promoting the pharmacy profession in Australia. However, a notable lack of female representation in these organisations' leadership roles has led to an increased focus on gender balance and equity.

Objective

To determine if the gender distribution in pharmacy leadership aligns with the pharmacy workforce in Australia (64% women) and how it has changed in the five years since our last study on the issue.

Setting

Australia.

Method

Eight key Australian pharmacy organisations were identified. The website for each organisation was accessed, and data were recorded for their 2023 boards/committees/councils based on annual reports. Data recorded include name, number of males, number of females, and the gender of the president/chair of each board/committee/council.

Results

Data were obtained for 340 separate professional committee members from the eight organisations (including state/territory branches) in 2023. Gender balance in pharmacy organisations has increased significantly since 2018, with women's representation in leadership positions now at 58% (47% 2018).

Conclusion

Gender equity within Australian pharmacy professional organisations has significantly progressed.

引言 在充满活力的医疗保健领域,药剂师在确保社区福祉方面发挥着至关重要的作用,而拥有坚实的专业组织来支持药剂师开展继续教育、宣传和制定服务标准等重要活动则是必不可少的。八个药剂师组织在代表各行业药剂师方面发挥着重要作用,共同为澳大利亚药剂师行业的发展、监管和推广做出了贡献。目标 确定药剂师领导层的性别分布是否与澳大利亚药剂师队伍(64% 为女性)相一致,以及自我们上次就此问题进行研究以来的五年间,该比例发生了怎样的变化。访问每个组织的网站,并根据年度报告记录其 2023 年董事会/委员会/理事会的数据。记录的数据包括每个董事会/委员会/理事会的名称、男性人数、女性人数以及主席/董事长的性别。结果获得了 2023 年八个组织(包括州/地区分支机构)340 名独立专业委员会成员的数据。自 2018 年以来,药学组织中的性别平衡显著增加,目前女性在领导岗位上的代表比例为 58%(2018 年为 47%).结论澳大利亚药学专业组织中的性别平等已取得显著进展。
{"title":"Gender balance in Australian pharmacy organisations: Are we there yet?","authors":"Thao Linh Pham ,&nbsp;Gregory M. Peterson ,&nbsp;Alicia Martin ,&nbsp;Mark Naunton","doi":"10.1016/j.rcsop.2024.100442","DOIUrl":"https://doi.org/10.1016/j.rcsop.2024.100442","url":null,"abstract":"<div><h3>Introduction</h3><p>In the dynamic landscape of healthcare, pharmacists play a critical role in ensuring the well-being of communities, and having solid professional organisations to support pharmacists is essential in crucial activities, including continuing education, advocacy and establishing service standards. Eight pharmacy organisations play vital roles in representing pharmacists in various sectors and collectively contribute to developing, regulating, and promoting the pharmacy profession in Australia. However, a notable lack of female representation in these organisations' leadership roles has led to an increased focus on gender balance and equity.</p></div><div><h3>Objective</h3><p>To determine if the gender distribution in pharmacy leadership aligns with the pharmacy workforce in Australia (64% women) and how it has changed in the five years since our last study on the issue.</p></div><div><h3>Setting</h3><p>Australia.</p></div><div><h3>Method</h3><p>Eight key Australian pharmacy organisations were identified. The website for each organisation was accessed, and data were recorded for their 2023 boards/committees/councils based on annual reports. Data recorded include name, number of males, number of females, and the gender of the president/chair of each board/committee/council.</p></div><div><h3>Results</h3><p>Data were obtained for 340 separate professional committee members from the eight organisations (including state/territory branches) in 2023. Gender balance in pharmacy organisations has increased significantly since 2018, with women's representation in leadership positions now at 58% (47% 2018).</p></div><div><h3>Conclusion</h3><p>Gender equity within Australian pharmacy professional organisations has significantly progressed.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100442"},"PeriodicalIF":0.0,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000386/pdfft?md5=ea8c03cfc14cb4c92536d3011249b767&pid=1-s2.0-S2667276624000386-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140643530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formal leadership perceptions about the autonomy of Pharmacy: a SWOT analysis 正式领导对药房自主权的看法:SWOT 分析
Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-10 DOI: 10.1016/j.rcsop.2024.100443
Fernando de Castro Araújo-Neto , Aline Santana Dosea , Francielly Lima da Fonseca , Thaís Maria Tavares , Déborah Mônica Machado Pimentel , Alessandra Rezende Mesquita , Divaldo Pereira de Lyra-Jr.

Introduction: Autonomy is considered a vital principle of professionalism. In recent years, despite important advances, the Pharmacy and pharmacists' autonomy has been questioned due to conflicts that jeopardize the consolidation of this profession in the division of work in health. Objective: to understand the construct of autonomy based on perceptions of formal leaders associated with professional organizations. Methods: A qualitative study was conducted through interviews with key informants. The data obtained were submitted to content analysis. Results: Perceptions about the autonomy in pharmaceutical practice were categorized according to strengths, weaknesses, opportunities, and threats to this construct. Conclusion: The findings allowed us to understand the autonomy of pharmaceutical practice in Brazil, generate hypotheses about the future of Pharmacy, and build strategies to maintain its occupational status.

导言:自主权被认为是专业精神的重要原则。近年来,尽管药剂学和药剂师取得了重大进展,但由于各种冲突,药剂学和药剂师的自主性一直受到质疑,这些冲突危及到这一职业在卫生分工中的巩固。目的:根据与专业组织相关的正式领导人的看法,了解自主性的构建。方法:通过对主要信息提供者的访谈进行了定性研究。对所获得的数据进行了内容分析。结果对制药实践中的自主性的看法按照这一概念的优势、劣势、机遇和威胁进行了分类。结论:研究结果让我们了解了巴西制药业的自主性,对药剂学的未来提出了假设,并制定了保持其职业地位的战略。
{"title":"Formal leadership perceptions about the autonomy of Pharmacy: a SWOT analysis","authors":"Fernando de Castro Araújo-Neto ,&nbsp;Aline Santana Dosea ,&nbsp;Francielly Lima da Fonseca ,&nbsp;Thaís Maria Tavares ,&nbsp;Déborah Mônica Machado Pimentel ,&nbsp;Alessandra Rezende Mesquita ,&nbsp;Divaldo Pereira de Lyra-Jr.","doi":"10.1016/j.rcsop.2024.100443","DOIUrl":"https://doi.org/10.1016/j.rcsop.2024.100443","url":null,"abstract":"<div><p>Introduction: Autonomy is considered a vital principle of professionalism. In recent years, despite important advances, the Pharmacy and pharmacists' autonomy has been questioned due to conflicts that jeopardize the consolidation of this profession in the division of work in health. Objective: to understand the construct of autonomy based on perceptions of formal leaders associated with professional organizations. Methods: A qualitative study was conducted through interviews with key informants. The data obtained were submitted to content analysis. Results: Perceptions about the autonomy in pharmaceutical practice were categorized according to strengths, weaknesses, opportunities, and threats to this construct. Conclusion: The findings allowed us to understand the autonomy of pharmaceutical practice in Brazil, generate hypotheses about the future of Pharmacy, and build strategies to maintain its occupational status.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"14 ","pages":"Article 100443"},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000398/pdfft?md5=2bfe8ea739a176b04e296b397b341275&pid=1-s2.0-S2667276624000398-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140554191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Exploratory research in clinical and social pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1